Effect of triptolide on aromatase activity in human placental microsomes and human placental JEG-3 cells

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 12, 2011, Pages 727-733

  Zhang, Juan ^a   Jiang, Zhenzhou ^a   Zhang, Luyong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Aromatase; Human placental JEG 3 cells; Human placental microsomes; Triptolide

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANDROGEN; AROMATASE; ESTROGEN; MESSENGER RNA; TRIPTOLIDE;

ARTICLE; CELL CULTURE; CELL LINE; CELL VIABILITY; CHORIOCARCINOMA; ENZYME ACTIVITY; FEMALE; HORMONE RELEASE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALE; MICROSOME; PLACENTA; PROTEIN EXPRESSION; REPRODUCTIVE TOXICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84455172868     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300594     Document Type: Article

References (57)

1. Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell. 2007;130(5):769-74. (Pubitemid 47332575)
2. Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 2007;13(8):353-61. (Pubitemid 47126989)
3. Tao XL, Sun Y, Dong Y, Xiao YL, Hu DW, Shi YP, et al. A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chin Med J (Engl.) 1989;102(5):327-32. (Pubitemid 19197370)
4. Tao X, Schulze-Koops H, Ma L, Cai J, Mao Y, Lipsky PE. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum. 1998;41(1):130-8. (Pubitemid 28041931)
5. Wang Z, Jin H, Xu R, Mei Q, Fan D. Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp Mol Med. 2009;41(10):717-27.
6. Dy Y. One hundred and forty-four cases of rheumatoid arthritis treated with Tripterygium wilfordii. J Trad Chin Med. 1983;3:125-9.
7. Qian SZ XY, Zhang JW. Recent progress in research on Tripterygium: a male antifertility plant. Contraception. 1995;51:121-9.
8. Qian SZ HY, Tong JS. Studies on the effect of T. wilfordii on the reproduction of men. Chin J Androl. 1989;3:129-32.
9. Lue Y, Sinha Hikim AP, Wang C, Leung A, Baravarian S, Reutrakul V, et al. Triptolide: a potential male contraceptive. J Androl. 1998;19(4):479-86. (Pubitemid 28397133)
10. Zhen QS, Ye X, Wei ZJ. Recent progress in research on Tripterygium: a male antifertility plant. Contraception. 1995;51(2):121-9.
11. Harper-Wynne, Ross C, Sacks G, Salter N, Nasiri J. Posttesticular antifertility action of triptolide in the male rat: evidence for severe impairment of cauda epididymal sperm ultrastructure. Cancer Epidemiol Biomarkers Prev. 2002;11(7):614-7
12. Sy Z. 5 cases report of Tripterygium wilfordii inducing premature ovarian failure. Sichuan Medicine. 1995;16(3):19-29.
13. Fu P MC, Gong Y. Study on sex hormone levels in Tripterygium wilfordii induced amenorrhea. J Clin Dermatol. 1999;28(6):163-4.
14. Shi JH WM, Liu XD. High gonadotropin and amenorrhea induced by Tripterygium wilfordii in two patients. Chin J New Drugs Clin Remed. 2003;22(10):635-6.
15. Gao YP JZ, Chen DF. The Effect of Tripterygium wilfordii Hook. f. on Uterin Leiomyoma. Acta Universitatis Medicinalis Secondae Shanghai. 2001;21(2):137-40.
16. Gao YP, Chen DF, Chang C. Effect of glycosides of Tripterygium wilfordii on uterus and blood supply of hysteromyoma patients. Shanghai Med J. 2002;25(4):237-9.
17. Fu YF LJ, Shi YP. The clinical observation on 26 cases of Endometriosis treated with Tripterygium wilfordii. Jiangsu Journal of Traditional Chinese Medicine. 1993;14(4):36-8.
18. Luo JH HZ. Tripterygium wilfordii treating the post-operation cases of endometriosis. J Clin Milit Surg. 2002;30(4):41-2.
19. Liu J, Jiang Z, Liu L, Zhang Y, Zhang S, Xiao J, et al. Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats. Drug Chem Toxicol. 2010;34(1):1-7.
20. Jing Liua Z, Xiao J, Zhang L. Effects oftriptolide from Tripterygium wilfordii on ERa and p53 expression in two human breast cancer cell lines. Phytomedicine. 2009;29: 1006-3.
21. Li H, Takai N, Yuge A, Furukawa Y, Tsuno A, Tsukamoto Y, et al. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells. Cancer Lett. 2010;297(2):198-206.
22. Stocco C. Aromatase expression in the ovary: hormonal and molecular regulation. Steroids. 2008;73:473-87.
23. Carreau S, Genissel C, Bilinska B, Levallet J. Sources of oestrogen in the testis and reproductive tract of the male. Int J Androl. 1999;22(4):211-23. (Pubitemid 29361234)
24. Saez JM. Leydig cells, endocrine, paracrine, and autocrine regulation. Endocr Rev. 1994;15(5):574-626. (Pubitemid 24328208)
25. Ishunina TA, Kruijver FP, Balesar R, Swaab DF. Differential expression of estrogen receptor alpha and beta immunoreactivity in the human supraoptic nucleus in relation to sex and aging. J Clin Endocrinol Metab. 2000;85(9):3283-91.
26. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005;57(3):359-383. (Pubitemid 41196955)
27. Schomberg DW, Couse JF, Mukherjee A, Lubahn DB, Sar Mayo KE, Korach KS. Targeted disruption of the estrogen receptor-a gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology. 1999;140:2733-44. (Pubitemid 32245153)
28. Schomberg DW, Couse JF, Mukherjee A, Lubahn DB, Sar M, Mayo KE, et al. Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology. 1999;140(6):2733-44. (Pubitemid 32245153)
29. Ni B, Zhu T, Jiang Z, Zhang R, Zhang T, Zhang L. In vitro and in silico approaches for analyzing the toxicological effect of triptolide on cx43 in sertoli cells. Toxicol Mech Methods. 2008;18(9):717-24. (Pubitemid 352790064)
30. Simpson ER, Michael MD, Agarwal VR, Hinshelwood MM, Bulun SE, Zhao Y. Cytochromes P450 11: expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB J. 1997;11(1):29-36. (Pubitemid 27076321)
31. Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, et al. Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol. 2007;106(1-5):81-96.
32. Kitaoka Y, Kitawaki J, Koshiba H, Inoue S, Ishihara H, Teramoto M, et al. Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters. J Steroid Biochem Mol Biol. 2004;88(2):183-9. (Pubitemid 38482035)
33. Hobler C, Andrade AJ, Grande SW, Gericke C, Talsness CE, Appel KE, et al. Sex-dependent aromatase activity in rat offspring after pre- and postnatal exposure to triphenyltin chloride. Toxicology .2010;276(3):198-205.
34. Carreau S, Wolczynski S, Galeraud-Denis I. Aromatase, oestrogens and human male reproduction. Philos Trans R Soc Lond B Biol Sci. 2010;365(1546):1571-9.
35. Lephart ED, Simpson ER. Assay of aromatase activity. Methods Enzymol. 1991;206:477-83.
36. Milczarek R, Sokolowska E, Hallmann A, Klimek J. The NADPH- and iron-dependent lipid peroxidation in human placental microsomes. Mol Cell Biochem. 2007;295(1-2):105-11. (Pubitemid 46157992)
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265-75.
38. Livak KJ, Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods Enzymol. 2001;25:402-8. (Pubitemid 34164012)
39. Eng ET, Williams D, Mandava U, Kirma N, Tekmal RR, Chen S. Anti-aromatase chemicals in red wine. Ann N Y Acad Sci. 2002;963:239-46. (Pubitemid 34721717)
40. Lipsky PE, Tao XL. A potential new treatment for rheumatoid arthritis: thunder god vine. Semin Arthritis Rheum. 1997;26(5):713-23. (Pubitemid 27190960)
41. Liu MX, Dong J, Yang YJ, Yang XL, Xu HB. [Progress in research on triptolide]. Zhongguo Zhong Yao Za Zhi. 2005;30(3):170-4. Article in Chinese.
42. Liu J, Jiang Z, Liu L, Zhang Y, Zhang S, Xiao J, et al. Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats. Drug Chem Toxicol. 2011;34(1):1-7.
43. Lue Y, Sinha Hikim AP, Wang, C. Triptolide: a potential male contraceptive. J Androl. 1998;19:479-86. (Pubitemid 28397133)
44. Zhen QS, Ye X, Wei ZJ. Recent progress in research on Tripterygium: a male antifertility plant. Contraception. 1995;51:121-9.
45. Fu P, Mao CS, Gong Y. Study on sex hormone levels in Tripterygium wilfordii induced amenorrhea. J Clin Dermatol. 1999;28(6):163-4.
46. Shoham Z, Schachter M. Estrogen biosynthesis-regulation, action, remote effects, and value of monitoring in ovarian stimulation cycles. Fertil Steril. 1996;65(4):687-701. (Pubitemid 26096902)
47. Yang JH, Luo SD, Wang YS, Zhao JF, Zhang HB, Li L. Triterpenes from Tripterygium wilfordii Hook. J Asian Nat Prod Res. 2006;8(5):425-9. (Pubitemid 44180285)
48. Bochkareva NV, Kondakova IV, Kolomiets LA, Muntian AB, Stukanov SL, Fomina SV. [Prognostic significance of assay of sex hormones, their receptors and enzymes involved in estrogen synthesis and metabolism in endometrial carcinoma]. Vopr Onkol. 2007;53(3):315-20. Article in Russian.
49. Madej P, Plewka A, Plewka D, Palen P, Nowaczyk G, Bogunia E, et al. The aromatase expression in myomas and myometriums of women in reproduction and perimenopausal age. Folia Histochem Cytobiol. 2009;47(3):497-504.
50. Wang L, Ye W, Liu X, Guo Y. [Combined use of steroid hormone and low dose gossypol for antifertility and its mechanism in rats]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000;22(3):214-9. Article in Chinese.
51. Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts. an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Cancer Res. 2001;61(5):2328-34. (Pubitemid 32692067)
52. Brodie A, Lu Q, Nakamura J. Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol. 1997;61(3-6):281-6. (Pubitemid 27455690)
53. Goss P. Anti-aromatase agents in the treatment and prevention of breast cancer. Cancer Control. 2002;9(2 Suppl):2-8. (Pubitemid 34457335)
54. A.U. Buzdar. A summary of second-line randomized studies of aromatase inhibitors. J Steroid Biochem Mol Biol. 2001;79:109-14. (Pubitemid 34162528)
55. Brodie AM, Njar VC. Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications. J Steroid Biochem Mol Biol. 1998;66(1-2):1-10. (Pubitemid 28335450)
56. Santner SJ, Feil PD, Santen RJ. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab. 1984;59(1):29-33. (Pubitemid 14087520)
57. Hong Y, Chen S. Aromatase, estrone sulfatase, and 17beta-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development. Mol Cell Endocrinol. 2010;340(2):120-6.